Features/News

VAP Test Helps Researchers Uncover Best Cholesterol Lowering Treatment for Type II Diabetes
LEARN MORE

Atherotech VAP Cholesterol Test
Meets Updated ADA, ACC Measurement and Treatment Guidelines for High
Risk Patients

LEARN MORE


THE VAP TEST
TREATMENT GUIDE
CASE HISTORIES
CLINICAL UPDATES
LITERATURE &
PUBLICATIONS

WELLNESS PARTNERS
HOMOCYSTEINE
& CRP TESTS

EVENTS
NEWS
CME
LICENSES &
ACCREDITATIONS
Clinical Updates


The VAP® Cholesterol Test as a Replacement for the Traditional Lipid Profile, by Paul Ziajka, M.D., Ph.D.



Heart Disease in Asian Indians—The Role of the VAP® Cholesterol Test, by Dr. Enas A. Enas, Director, Coronary Artery Disease in Asian Indians (CADI) Foundation



The VAP® Cholesterol Test—Its Role in Secondary CHD Prevention & Patients with Elevated Triglycerides



Women and Cardiovascular Disease—The Role of the VAP® Cholesterol Test in an OB/Gyn Practice, by Steven Foley, M.D., F.A.C.O.G., Advanced Gynecology



Understanding Non-HDL-C, Apo-B, and Particle Number, and the need for the VAP® Cholesterol Test, by Paul Ziajka, M.D., Ph.D.



Lindora Medical Clinics Use VAP® Cholesterol Test to Help Patients Achieve “Metabolic Equilibrium,” by Dr. Sabina Kobylinski, Medical Director, Lindora Medical Clinics



The VAP® Cholesterol Test in the Treatment of HIV-Positive Patients with Lipodystrophy and Dyslipidemia, by Paul Ziajka, M.D., Ph.D.



Preventing Heart Disease in America’s Baby Boomers with the VAP® Cholesterol Test, by Michael D. Ozner, M.D.




Home | Contact Us | Privacy Policy |  © 2008 Atherotech